Thursday, May 10, 2012 4:32:14 PM
US Panel Gives Nod To New Obesity Drug
Last update: 5/10/2012 4:23:30 PM
WASHINGTON (AFP)--A panel of independent experts on Thursday urged the U.S. Food and Drug Administration to approve the first new anti-obesity drug in more than a decade--Lorcaserin, made by Arena Pharmaceuticals Inc. (ARNA).
The committee voted 18-4 in favor of the drug, which works to control the appetite through receptors in the brain, after trial data showed it helped nearly half of patients studied lose up to 5% of their body weight.
(END) Dow Jones Newswires
May 10, 2012 16:23 ET (20:23 GMT)
North Bay Resources Announces Mt. Vernon Gold Mine Startup, Sierra County, California • NBRI • Aug 5, 2024 9:00 AM
Fifty 1 Labs, Inc. and All-In-Extracts Announce Joint Venture to Develop and Release New Testosterone Boosting Supplement • BLEG • Aug 5, 2024 8:30 AM
Kona Gold Beverages, Inc. Announces Strategic Initiatives and Corporate Direction Changes • KGKG • Aug 2, 2024 2:00 PM
POET and Luxshare Tech Expand Product Offerings for Artificial Intelligence Networks • POET • Aug 1, 2024 9:28 AM
Management Discusses Financial Filings of Global Arena Holding Inc., for 10-K 2023 and 10-Q, 1st Quarter 2024 • GAHC • Aug 1, 2024 9:14 AM
VAYK Announces LOI to Acquire $1 Million Home Service Company to Support Airbnb Business • VAYK • Aug 1, 2024 9:00 AM